Children's Cancer and Leukaemia Group
Clinical Trials
Introduction to Clinical Trials

What is a multi-centre trial?

With a comparatively rare disease, it would not be feasible to accrue sufficient numbers of patients to conduct a trial in a single centre. Hence the need for multi-centre trials, such as are conducted within UKCCSG, and these may be national or international.

Multi-centre trials have the advantage that patient accrual is quicker so that the trial can be made larger and/or the intended size is reached more quickly. The end result should be that a multi-centre trial reaches more reliable conclusions at a faster rate so that overall progress in the treatment of a disease is enhanced. By involving patients from several centres, any conclusions have a broader more representative base than can be reached in a single centre. The conduct of multi-centre trials has implications for: complex administration and planning; expensive so need to ensure adequate funding; need for good communication and standardisation between all participants.

>>>> Role of coordinating centre/Trials Unit >>>>

  1. Introduction
  2. What is a Clinical Trial?
  3. Clinical Trial procedure
  4. The role of the Chief Investigator
  5. The Protocol
  6. How is the size of a clinical trial determined?
  7. What is a multi-centre trial?
  8. Role of coordinating centre/Trials Unit
  9. What is randomisation?
  10. How is a patient randomised for a particular trial?
  11. What is a control in clinical trials?
  12. Forms and data management
  13. Statistics in clinical trials
  1. The role of the trial coordinator
  2. Follow up
  3. How is the trial data analysed/evaluated?
  4. What are pharmacokinetic studies?
  5. Ethical issues
  6. Conduct of Clinical Trials/Research
  7. What is a blind trial?
  8. Interpretation and publication of findings
  9. Survival Curves
  10. CCLG Protocols – development and approval process
  11. References
  12. Download PDF